Across Europe, budgets are being restructured towards defence.
Cuts to aid budgets and slashed research investment – along with the stalled rollout of a so-called ‘miracle’ HIV prevention drug – may be putting millions of lives at risk from the disease up to 2030, according to health experts.
The EU and other Western governments need to step up their funding commitments to AIDS programmes or risk a reversal of progress on ending HIV as a public health emergency by 2030 — at least those are the findings from a recent study from The Lancet last month.
But among competing issues like defence and strategic partnerships to secure critical raw materials in Europe, the rollout of new drugs and prevention efforts could be sidelined, public health experts told Euractiv.
Read the full news story at Euractiv.
Source : Euractiv
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.